Rapid increase in trade and a growing air passenger market encourages high travel volume between the regions associated with increasing risks of such importations including China. Eleven Chinese workers infected during the 2016 yellow fever (YF) outbreak in Angola imported YF into China highlighting the potential for spread into Asia. Using outbound and inbound travel data, we assessed travel patterns from and to YF endemic countries in relation to China. Among YF endemic countries, Angola has the second highest number of travellers into China and also receives the second highest number of Chinese visitors. We estimated that China needs around half a million YF vaccine doses to cover their population travelling to YF endemic countries. The recent importation cases into China also unmasked the low YF vaccination coverage among Chinese travellers and workers to Angola, indicating the need to ensure better adherence to the International Health Regulations.
Introduction
The highest increase in international arrivals in 2016 was recorded in Asia and the Pacific region, with a robust growth in all the Asian sub-regions. 1 According to the UN World Tourism Office (UNWTO), Asia and the Pacific is expected to witness the strongest growth in tourist arrivals, where the forecast suggests an increase by 331 million over the 2010-30 period to reach 535 million in 2030 with a growth of 4.9% per year. 1 Increasing connectivity to Asia will also result in increasing importation of infectious diseases. Information on air traffic can be used to predict the risks of importation of infectious diseases, as shown for vector-borne disease importation. 2 The risk of importation is strongly associated with the incidence of a certain communicable disease in the country of origin (country of disembarkation) combined with the travel volume from that country to a destination country. [3] [4] [5] Hence, travel volume data present an additional tool to estimate the magnitude of international spread and identify vulnerable receiving countries for various diseases such as has been published for H1N1, 6 polio, 7 dengue 8-10 and Zika. [11] [12] [13] Recent decades have witnessed an unprecedented emergence of epidemic arbovirus diseases. 14 The most recent example is Zika virus infection, which moved from obscurity to become a public health emergency of international concern that rapidly spread across international borders, 15 and rapidly spread through international travellers, including to China. 16, 17 In the year 2016, Yellow fever virus (YF) almost became the next arbovirus to be declared a public health emergency of international concern. A yellow fever epidemic began in Angola, a country with a population size of 25 021 974, 18 in December 2015 in the capital Luanda, and by September 2016, a total of 884 laboratory confirmed cases had been reported with 373 deaths. 19 International travel within the African continent led to spread to Kenya, the Democratic Republic of the Congo (DRC), strongly driven by population densities. 20 However, of even greater concern was that for the first time in human history, during 2016 laboratory-documented YF was exported to Asia via international travellers, putting 1.8 billion people at risk because the urban mosquito vector (Aedes aegypti) is present among large unvaccinated populations. to sseek treatment and was tested positive for yellow fever. On March 13, the National Health and Family Planning Commision of China reported this first case of yellow fever in Asia. 22 Within 3 weeks, 8 more imported cases were reported from the provinces of Fujian (n ¼ 6), Jiangsu (n ¼ 1) and Sichuan (n ¼ 1). By 12 April 2016, two more cases from Fujian and Jiangsu province were identified, bringing it to a total of 11 laboratory confirmed cases, all imported from Angola. 23 Six of them were fatal, including the first infected patient. These eleven Chinese workers who imported YF from Angola to China were the first laboratory documented YF cases in Asia. 24 Here, we estimated the extent of Chinese travellers to YF endemic countries and the air passenger volumes from YF endemic countries into China to assess the potential risk of YF introduction into China. We also calculated the approximate demand for YF vaccines in China to ensure adequate vaccine coverage of Chinese travelling to YF endemic countries.
Methods
We obtained data on travel volume from the World Tourism Organization (UNWTO) through the Statistics and Tourism Satelite Account. As data for 2015 and 2016 were not yet available, and data for 2013 and 2014 incomplete, we used data for the year 2012. For Angola, data only existed for the year 2013. The country specific outbound tourism data were defined as air passenger travel numbers by residents from China to YF endemic countries. 25 The inbound travel data represent the number of travellers from yellow fever endemic countries into China in 2012. YF endemic countries were identified through the World Health Organization (WHO) International travel and health publication (www.who.int/ihr).
Results
We found that a total of 475 761 air passengers departed from YF endemic countries to China in 2012. The highest travel volume from a YF endemic country in the Latin America continent to China was Brazil (n ¼ 99 445), followed by Venezuela (n ¼ 36 648), Colombia (n ¼ 34 315) and Argentine (n ¼ 24 883). Among the African countries, the highest travel volumes were from Nigeria (n ¼ 38 852), Angola (n ¼ 24 998), Ethiopia (n ¼ 23 086) and Ghana (16 918) ( Table 1) . The overall travel volume of Chinese travellers out of China into YF endemic countries in 2012 was 466 832, the majority of which travelled to Nigeria (n ¼ 227 694), Angola (n ¼ 69 334) and Brazil (n ¼ 65 954). Figure 1 shows all the YF endemic countries that were visited by Chinese travellers.
Discussion
Given the vulnerability of Asia for potential YF outbreaks due to the presence of Aedes aegypti, our findings highlight the substantial number of air travellers from YF endemic countries to China. Such travel volume data can help policy-makers identify YF countries at highest risk of exporting YF into China, and also aid to estimate the extent of YF importations into China from YF endemic countries, by applying recently developed mathematical models to estimate the importation risk. 26 Furthermore, our data can also be used for demand forecasting of yellow fever vaccines in China. Given the amount of 466 832 travellers from China to YF endemic countries in 1 year, the estimated amount for annual YF vaccines for persons departing from China is around half a million vaccine doses (not taking into account frequent travellers who will only need one life-time dose). The importation of YF via unvaccinated Chinese workers also highlights the shortcoming that these individuals were able to circumvent the YF vaccination mandated by the International Health Regulations (IHR). According to IHR, proof of vaccination is required for entry into China from certain YF endemic countries, including Angola.
A safe and effective yellow fever vaccine that produces rapid and long duration (probably lifelong) immunity has been available for more than half a century. Mass vaccination is highly effective, but would require over 300 million doses for Africa alone, and vaccine coverage remains inadequate as underscored by the current outbreak in Angola and other parts in Africa. The annual production limits of about 80 million doses per year would clearly not be able to cover the at risk population should yellow fever spread to Asia. 21 Various WHO pre-qualified yellow fever vaccine manufacturers exist globally, including one in China. Hence, yellow fever 17D vaccine is manufactured in China for the domestic market so there is vaccine available, albeit limited. Introduction of yellow fever vaccine into routine infant immunization in YF endemic countries is a long-term strategy but takes decades before protection of the entire population is achieved. Hence, in addition to strengthening vaccine coverage in YF endemic countries, the emphasis remains on ensuring vaccination of individuals crossing borders in order to prevent international spread. Circumventing the IHR regulations by fabricating false YF vaccine certificates (without having administered the YF vaccine) needs to be stopped by better regulations and legislations. Governments around the world including China need to ensure that their citizens obtain YF vaccination when travelling to countries where such vaccines are recommended in order to protect individuals; and governments also need to tighten border controls to ensure that incoming travellers from YF endemic countries will be checked for proof of YF vaccination. Public policies should become a priority in the prevention of diseases among travellers, especially when diseases are preventable by vaccines such as yellow fever. All measures need to be taken to protect global health security, particularly for vulnerable Asian countries that have shown an exponential increase in travel volume such as China.
